Cargando…
Evaluation of the Effect of a Novel β3-Adrenergic Agonist on Choroidal Vascularity
PURPOSE: To determine the effect of the new β(3)-agonist (mirabegron), which is used for overactive bladder (OAB) treatment, on central retinal thickness (CRT) and choroidal vascularity. MATERIAL AND METHODS: The 26 eyes of 26 cases using 50 mg tablet mirabegron once per day for OAB were included in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287045/ https://www.ncbi.nlm.nih.gov/pubmed/34241623 http://dx.doi.org/10.1167/iovs.62.9.17 |